GIPR : incretin reinforcement
Ideal Candidates: Individuals struggling with severe alcohol or substance cravings who want a modern, evidence-based approach combined with structured therapy
Engage in healthy distractions The brain is not wired to multitask, which may surprise you, given how much our society talks about it
Specific injection timing, dose escalation schedules, and individual protocol decisions belong in a clinical conversation with a qualified prescriber
Samms RJ, Coghlan MP, Sloop KW (2020) How may GIP enhance the therapeutic efficacy of GLP-1
That 36.6-pound average, in people who had been diabetic for a mean of just 2.5 years, is a signal that the glucagon receptor component the distinguishing third arm of this GIP/GLP-1/glucagon triple agonist is doing real metabolic work beyond what dual agonism alone achieves